The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences
Tick (check) box to add article to PDF "basket"
How do vaccination programmes influence child survival in low-income countries? Protection against the targeted illness is not the only aspect to consider, according to an EU-funded project that explored associated outcomes known as 'non-specific effects'. The research focused on public health interventions in Burkina Faso, Ghana and Guinea-Bissau.
Published: 3 October 2018
An EU- and industry-funded project has built an extensive public-private network to speed up the development of treatments to combat antibiotic-resistant bacteria that cause infections in intensive care units, helping address a major issue for hospitals.
Published: 3 September 2018
As more and more people travel and global warming paves the way for diseases to spread, human health and welfare are no longer the preserve of single countries, regions or even continents. European researchers teamed up with African partners to bridge the gap in biomedical research and biobanking practices between the regions. Its biobank-in-a-box is now ready to be unwrapped.
Published: 22 August 2018
An EU-funded project developed a simple, affordable and effective vaccine strategy to prevent the incidence of both hepatitis C virus and HIV-1. This could significantly increase the life expectancy of people receiving antiretroviral therapy for HIV-1.
Published: 27 July 2018
An EU-funded project aims to identify and maximise the potential of novel vaccines to end the global tuberculosis epidemic. These could save lives, stem the spread of infection and shorten treatment for the often deadly, airborne disease.
Published: 21 June 2018
Hundreds of millions of people each year are infected with Plasmodium vivax, the most widespread form of malaria worldwide. An EU-funded project is tackling the mosquito-borne parasite, leading cutting-edge research efforts to accelerate the development of effective vaccines.
Published: 25 April 2018
EU-funded researchers are using the latest vaccine technologies and antigen discovery tools to develop a multi-stage, multi-antigen vaccine against Plasmodium falciparum, the parasite responsible for the deadliest form of malaria.
Published: 25 April 2018
Using innovative nanotechnologies, an EU-funded project is developing more efficient and sustainable vaccine manufacturing processes. The cost of vaccines puts a brake on wider immunisation, so these new processes will find broad application - especially in developing economies.
Published: 19 February 2018
The virus that causes chickenpox can also lead to more serious and painful conditions in older people. An EU-funded researcher is discovering how the virus interacts with the immune system and, possibly, how it might be controlled.
Published: 14 November 2017
Published: 10 November 2017